Copyright
        ©The Author(s) 2024.
    
    
        World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2439-2448
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2439
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2439
            Table 1 Clinicopathologic characteristics of the patients and hepatic observations, n (%)
        
    | Characteristic | Value | 
| Patient (n = 331) | |
| Mean age (yr)1 | 57.5 ± 10.9 | 
| Sex | |
| Male | 236 (71.3) | 
| Female | 95 (28.7) | 
| Cause of liver disease | |
| Hepatitis B virus | 244 (73.7) | 
| Hepatitis C virus | 51 (15.4) | 
| Hepatitis B and C virus | 9 (2.7) | 
| Alcohol | 10 (3.0) | 
| Autoimmune | 4 (1.2) | 
| NASH | 3 (0.9) | 
| Cirrhosis of unknown cause | 10 (3.0) | 
| Number of observations per patient | |
| 1 | 309 (93.4) | 
| 2 | 19 (5.7) | 
| 3 | 3 (0.9) | 
| Observation (n = 356) | |
| Size (mm)1 | |
| Overall | 31.5 ± 25.9 | 
| HCC | 35.8 ± 27.1 | 
| Non-HCC malignancy | 43.2 ± 27.8 | 
| Benign lesion | 21.0 ± 19.2 | 
| Final diagnosis | |
| HCC | 215 (60.4) | 
| Non-HCC malignancy | 25 (7.0) | 
| ICC | 7 (2.0) | 
| CHC | 8 (2.2) | 
| Metastasis | 5 (1.4) | 
| Sarcomatoid carcinoma | 4 (1.1) | 
| Neuroendocrine carcinoma | 1 (0.3) | 
| Benign lesion | 116 (32.6) | 
| Haemangioma | 14 (3.9) | 
| DN | 24 (6.7) | 
| RN | 42 (11.8) | 
| FNH-like | 17 (4.8) | 
| Adenoma or adenomatoid hyperplasia | 5 (1.4) | 
| Abscess | 2 (0.6) | 
| Angiomyolipoma | 2 (0.6) | 
| Epithelioid angiomyolipoma | 3 (0.8) | 
| Abnormal perfusion | 7 (2.0) | 
| Standard reference of diagnosis | |
| Pathologic diagnosis | 286 (80.3) | 
| Typical imaging features and follow-up | 70 (19.7) | 
| The time of follow-up (months)1 | 32.3 ± 13.5 | 
            Table 2 The observation categories according to the liver imaging reporting and data system
        
    | LI-RADS category | LI-RADS v2018 | sLI-RADS A | sLI-RADS B | sLI-RADS C | sLI-RADS D | F-sLI-RADS | ||||||
| HCC | non-HCC | HCC | non-HCC | HCC | non-HCC | HCC | non-HCC | HCC | non-HCC | HCC | non-HCC | |
| 1 | 0 | 42 | 0 | 42 | 0 | 42 | 0 | 42 | 0 | 42 | 0 | 42 | 
| 2 | 1 | 38 | 1 | 38 | 1 | 38 | 1 | 38 | 1 | 38 | 1 | 38 | 
| 3 | 11 | 13 | 16 | 28 | 1 | 2 | 11 | 13 | 11 | 13 | 7 | 13 | 
| 4 | 15 | 19 | 21 | 4 | 22 | 26 | 64 | 25 | 9 | 18 | 6 | 14 | 
| 5 | 187 | 14 | 176 | 14 | 190 | 18 | 138 | 8 | 193 | 15 | 200 | 19 | 
| M | 1 | 15 | 1 | 15 | 1 | 15 | 1 | 15 | 1 | 15 | 1 | 15 | 
| Total | 215 | 141 | 215 | 141 | 215 | 141 | 215 | 141 | 215 | 141 | 215 | 141 | 
            Table 3 Diagnostic performance of the liver imaging reporting and data system for hepatocellular carcinoma, %
        
    | Sensitivity | Specificity | PPV | NPV | Accuracy | Youden | |
| LI-RADS v2018 | 87.0 | 90.1 | 93.0 | 81.9 | 88.2 | 0.770 | 
| sLI-RADS A | 81.9 | 90.1 | 92.6 | 76.5 | 85.1 | 0.719 | 
| sLI-RADS B | 88.4 | 87.2 | 91.3 | 83.1 | 87.9 | 0.756 | 
| sLI-RADS C | 64.2 | 93.6 | 93.9 | 63.2 | 75.8 | 0.578 | 
| sLI-RADS D | 89.8 | 89.4 | 92.8 | 85.1 | 89.6 | 0.791 | 
| F-sLI-RADS | 93.0 | 86.5 | 91.3 | 89.1 | 90.4 | 0.795 | 
| aPvalue | 0.001 | > 0.999 | — | — | 0.001 | — | 
| bPvalue | 0.250 | 0.125 | — | — | > 0.999 | — | 
| cPvalue | < 0.001 | 0.031 | — | — | < 0.001 | — | 
| dPvalue | 0.031 | > 0.999 | — | — | 0.062 | — | 
| ePvalue | < 0.001 | 0.062 | — | — | 0.008 | — | 
| fPvalue | 0.016 | 0.125 | — | — | 0.250 | — | 
- Citation: Lyu R, Hu WJ, Wang D, Wang J, Ye YB, Jia KF. Simplified liver imaging reporting and data system for the diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging. World J Gastrointest Oncol 2024; 16(6): 2439-2448
 - URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2439.htm
 - DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2439
 
